| Filed On | Filing |
|---|---|
| 05 Oct 2026 |
8-K/A: Other Events
You should carefully consider the risks described below, as well as general economic and business risks and the other information herein. The occurrence of any of the events or circumstances described below or other adverse events could ... |
| 16 Sep 2025 |
8-K/A: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
Processa Pharmaceuticals, Inc. (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”), hereby certifies as follows: |
| 14 Aug 2025 |
8-K/A: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
This Securities Purchase Agreement (this “Agreement”) is dated as of August 4, 2025, between Processa Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, inclu... |
| 24 Jan 2018 | 8-K/A: Financial Statements and Exhibits |
| 17 Oct 2017 | 8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +4 more |
| 22 Sep 2015 | 8-K/A: Changes in Registrant's Certifying Accountant |
Loading...
